361 Results (Page 1 of 15)
Saudi Arabia Markets Research Reports
Saudi Arabia Lipid Disorder Therapeutics Market Analysis
The Saudi Arabia Lipid Disorder Therapeutics Market was valued at $811.9 Mn in 2023 and is predicted to grow at a CAGR of 14.13% from 2023 to 2030, to $2,047.9 Mn by 2030. Saudi Arabia Lipid Disorder Therapeutics Market is growing due to Growing Awareness and diagnosis rates, advancements in treatment options, and increasing healthcare expenditure. The industry is primarily dominated by players such as Sanofi, Sun Pharmaceutical Industries Ltd., AstraZeneca PLC, Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Amgen Inc., Takeda Pharmaceutical Company Limited, AbbVie Inc., Viatris, and Dr. Reddys Laboratories Ltd.
Saudi Arabia Head and Neck Cancer Therapeutics Market Analysis
The Saudi Arabia Head and Neck Cancer Therapeutics Market was valued at $98.07 Mn in 2023 and is predicted to grow at a CAGR of 14.00% from 2023 to 2030, to $245.40 Mn by 2030. The key drivers of this industry include government initiatives, advanced treatment options, and growing medical tourism. The industry is primarily dominated by players such as Pfizer, Merck, Novartis, and AstraZeneca among others.
Saudi Arabia Bariatric Surgery Devices Market Analysis
The Saudi Arabia Bariatric Surgery Devices Marketwas valued at $45.2 Mn in 2023 and is projected to grow at a CAGR of 6.7% from 2023 to 2023, to $71.2 Mn by 2030. Major factors driving the market for bariatric surgical devices include the rising incidence of adult obesity brought on by altered lifestyle patterns and excessive calorie consumption. The demand for bariatric operations is also anticipated to rise over the forecast period due to increased government backing and growing public awareness of the market's unhealthy food and beverage offerings and how they affect BMI, thus driving the market growth of the Bariatric Surgery Devices. The prominent players in the market are Conmed Corporation, Allergan, Medtronic, B. Braun, Asenus Surgical, Johnson & Johnson, Cousin Surgery among others.
Saudi Arabia Contact Lenses Market Analysis
Saudi Arabia Contact Lenses Market was valued at $291.38 Mn in 2023 and is predicted to grow at a CAGR of 10.4% from 2023 to 2030, to $582.43 Mn by 2030. The key drivers of this industry include rising disposable income, high prevalence of eye issues, and increasing focus on aesthetics. The industry is primarily dominated by Bausch and Lomb, CooperVision, Alcon Vision, and Essilor among others.
Saudi Arabia Genomics Market Analysis
The Saudi Arabia Genomics market was valued at $555.1 Mn in 2023 and is predicted to grow at a CAGR of 18% from 2023 to 2030, to $1,768.1 Mn by 2030. The key drivers of the market include rising prevalence of diseases, increasing applications of genomics, the need for advancements in cancer treatments, and the rising demand for personalized medicines. The prominent players of the Saudi Arabia Genomics Market are NoorDx, Al Farabi Labs, Novo Genomics, Anwa Labs, Saudi Advanced Medical Lab (SAML), Saudi-German Genomic Centre, among others.
Saudi Arabia Kidney Cancer Therapeutics Market Analysis
The Saudi Arabia Kidney Cancer Therapeutics Market was valued at $106.93 Mn in 2023 and is predicted to grow at a CAGR of 6.36% from 2023 to 2030, to $164.64 Mn by 2030. The key drivers of this industry include the increasing prevalence of kidney cancer due to lifestyle and environmental factors, early detection, and advancement in diagnostic tools. The key players in the industry are Pfizer, AbbVie Biopharmaceuticals GmbH, F. Hoffmann-La Roche, Johnson & Johnson Middle East, and Merck Serono Middle East.
Saudi Arabia Medical Digital Imaging System Market Analysis
The Saudi Arabia Medical Digital Imaging System Market was valued at $518.5 Mn in 2023 and is predicted to grow at a CAGR of 9.7% from 2023 to 2030, to $991.28 Mn by 2030. The key drivers of this industry include government initiatives, infrastructure development, and rising chronic diseases. The industry is primarily dominated by players such as Siemens Healthineers, GE Healthcare, Philips Healthcare, and Canon Medical Systems among others.
Saudi Arabia Dental Caries Detectors Market Analysis
The Saudi Arabia Dental Caries Detectors Market was valued at $3.9 Mn in 2023 and is predicted to grow at a CAGR of 10.4% from 2023 to 2030, to $7.8 Mn by 2030. Saudi Arabia Dental Caries Detectors Market is growing due to Increasing Dental Awareness and Education, High Prevalence of dental caries, and Advanced imaging and diagnostic. The market is primarily dominated by players such as EXIR Medical Clinic, Abeer Medical Group, Jeddah National Hospital, Sigal Clinics, Smile 360, Pacific Dental Services, Dental Services Group, Sirona Dental Systems, Dentsply Sirona, KaVo Kerr, Ivoclar Vivadent, and Planmeca.
Saudi Arabia Exosome Research Market Analysis
The Saudi Arabia Exosome Research Market was valued at $1.1 Mn in 2023 and is projected to grow at a CAGR of 17.23% from 2023 to 2023, to $3.3 Mn by 2030. The key drivers of this industry are increasing prevalence and incidences of cancer and various auto-immune diseases, rising healthcare expenditure for better health services, growing R&D activities associated with exosome research, technological advancements in exosome isolation and analytical procedures, and increasing advanced applications of exosomes. The industry is primarily dominated by players such as Hologic Inc., Luminex Corporation, QIAGEN, Agilent Technologies among others.
Saudi Arabia Clinical Nutrition for Diabetes Care Market Analysis
The Saudi Arabia Clinical Nutrition for Diabetes Care Market was valued at $36.55 Mn in 2023 and is predicted to grow at a CAGR of 6.28% from 2023 to 2030, to $55.98 Mn by 2030. The key drivers of this industry include increasing the prevalence of diabetes, advancements in nutritional science, and initiatives for diabetes management. The key players in the industry are Sanofi, Nestlé Health Science, Danone Nutricia, and Novo Nordisk among others.
Saudi Arabia Pharmacy Automation Device Market Analysis
The Saudi Arabia Pharmacy Automation Device Market was valued at $93.5 Mn in 2023 and is predicted to grow at a CAGR of 11.4% from 2023 to 2030, to $199.1 Mn by 2030. Saudi Arabia Pharmacy Automation Device Market is growing due to Increasing Demand for Efficiency, Adoption of Electronic Health Records, Increasing adoption among end-users. The market is primarily dominated by players such as Becton Dickinson and Co, Capsa Solutions LLC, Omnicell Inc, Oracle Corp, Veradigm LLC, Swisslog Healthcare AG, McKesson Corporation.
Saudi Arabia Cardiac Pacemakers Market Analysis
The Saudi Arabia Cardiac Pacemakers Market was valued at $68.80 Mn in 2023 and is predicted to grow at a CAGR of 4.7% from 2023 to 2030, to $94.89 Mn by 2030. The key drivers of this industry include government initiatives, growing aging population, and technological advancements. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.
Saudi Arabia Clinical Nutrition for Cancer Care Market Analysis
The Saudi Arabia Clinical Nutrition for Cancer Care Market was valued at $95.7 Mn in 2023 and is predicted to grow at a CAGR of 6.54% from 2023 to 2030, to $149.1 Mn by 2030. The key drivers of the market include the increasing prevalence of cancer, improved healthcare infrastructure, and rising disposable incomes. The prominent players of the Saudi Arabia Clinical Nutrition for Cancer Care Market are Almarai, Nestlé Health Science, Abbott Nutrition, B. Braun Melsungen AG, and Fresenius Kabi, among others.
Saudi Arabia Gram-Negative Infection Therapeutics Market Analysis
The Saudi Arabia Gram-Negative Infection Therapeutics Market was valued at $0.25 Bn in 2023 and is predicted to grow at a CAGR of 7.4% from 2023 to 2030 to $0.42 Bn by 2030. Factors driving this market growth include increasing prevalence, the threat of nosocomial pneumonia, and an aging population. Prominent companies in this market include Baxter, Novartis, and others.
Saudi Arabia Home Infusion Therapy Market
The Saudi Arabia Home Infusion Therapy Market was valued at $611.3 Mn in 2023 and is predicted to grow at a CAGR of 9.6% from 2023 to 2030, to $1161.3 Mn by 2030. The key drivers of the market include rising prevalence of chronic diseases, expanding geriatric population, and technological advancements. The prominent players of the Saudi Arabia Home Infusion Therapy Market are Baxter International, ICU Medical (Smiths Medical), Becton, Dickinson and Company (BD), and Fresenius Kabi, among others.
Saudi Arabia Hepatitis A Therapeutics Market Analysis
The Saudi Arabia Hepatitis A Therapeutics Market was valued at $12.53 Mn in 2023 and is predicted to grow at a CAGR of 3.7% from 2023 to 2030 to $16.16 Mn by 2030. Key industry drivers include the increased market demand due to the higher incidence of hepatitis A among males (55%) and Saudi nationals (88%) compared to females and other nationalities in Saudi Arabia. Prominent companies in this sector, such as F. Hoffmann-La Roche Ltd. and Sanofi, play a significant role.
Saudi Arabia Nutritional Supplements Market Analysis
By 2030, it is anticipated that the Saudi Arabia Nutrition and Supplements market will reach a value of $11.8 Bn from $6.49 Bn in 2022, growing at a CAGR of 7.8% during 2022-2030. The nutrition and supplements market in Saudi Arabia is primarily dominated by local players such as Vitabiotics Ltd, SEWAR, and BIOVEA. The market for nutrition and supplements in Saudi Arabia is primarily driven by an inclination towards better health infrastructure, government regulations and increasing consumer awareness of health and lifestyle. The Saudi Arabia nutrition and supplements market is segmented by Type, Product, application, and Distribution Channel.
Saudi Arabia Lymphoma Therapeutics Market Analysis
Saudi Arabia's Lymphoma Therapeutics Market was valued at $557.89 Mn in 2023 and is predicted to grow at a CAGR of 9.80% from 2023 to 2030, to $1,073.40 Mn by 2030. The key drivers of this industry include a high lymphoma incidence rate, rising healthcare expenditure, and the geriatric population. The industry is primarily dominated by AstraZeneca PLC, Bayer AG, Bristol Myers Squibb Company, F. Hoffmann-La Roche Ltd, and Johnson & Johnson among others.
Saudi Arabia Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market Analysis
This report presents a strategic analysis of the Saudi Arabia Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Saudi Arabia Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market, offering unmatched value, accuracy and expert insights.
Saudi Arabia Constipation Therapeutics Market Analysis
Saudi Arabia Constipation Therapeutics Market was valued at $309 Mn in 2022 and is estimated to reach $573 Mn in 2030, exhibiting a CAGR of 8% during the forecast period. The constipation therapeutics market is growing driven by the global rise in constipation prevalence associated with aging, sedentary lifestyles, and poor dietary habits, and further fuelled by an expanding elderly population more prone to chronic conditions. Key players in this industry include Abbott, Almirall, Boehringer Ingelheim, GlaxoSmithKline, Johnson & Johnson, Medtronic, Norgine Pharmaceuticals, Pfizer, Sanofi, and Takeda Pharmaceutical.
Saudi Arabia COVID-19 Clinical Trials Market Analysis
This report presents a strategic analysis of the Saudi Arabia COVID-19 Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Saudi Arabia COVID-19 Clinical Trials Market, offering unmatched value, accuracy, and expert insights.
Saudi Arabia Over The Counter (OTC) Analgesics Market Analysis
This report presents a strategic analysis of the Saudi Arabia Over The Counter (OTC) Analgesics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Saudi Arabia Over The Counter (OTC) Analgesics Market, offering unmatched value, accuracy and expert insights.
Saudi Arabia Pain Management Devices Market Analysis
This report presents a strategic analysis of the Saudi Arabia Pain Management Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Saudi Arabia Pain Management Devices Market, offering unmatched value, accuracy and expert insights.
Saudi Arabia Conjunctivitis Therapeutics Market Analysis
The Saudi Arabia Conjunctivitis Therapeutics Market was valued at $70 Mn in 2022 and is predicted to grow at a CAGR of 6.9% from 2023 to 2030, to $119 Mn by 2030. The key drivers of this industry include the increasing prevalence of conjunctivitis, new product innovations, and supportive government initiatives in the therapeutics industry. The industry is primarily dominated by players such as Jawa, Ajanta, AbbVie, Alembic, Grevis, Cipla, and Bausch Health among others.
Saudi Arabia Electronic Health Records Market Analysis
Saudi Arabia's Electronic Health Record (EHR) market size was valued at $448 Mn in 2022 and is estimated to expand at a CAGR of 5.5% from 2022 to 2030 and will reach $738 Mn in 2030. Saudi Arabia's EHR market growth can be attributed to the surging need for remote monitoring and chronic disease management. The market is segmented by product type, application type, and end user. The key market players are Al Muhaidib Group (SAU), Sada Systems (SAU), Allscripts, Cerner, and others.